Acceptability of self-taken vaginal for early detection of HPV DNA in women with limited access to health services: An alternative to increase the coverage in a state of the Mexican Republic
- 1 Nursing Faculty, Autonomic University of San Luis Potosí, San Luis Potosí, México
- 2 Nursing Faculty, Autonomic University of San Luis Potosí, San Luis Potosí, México;
- 3 Faculty of Nurse and Nutriology, Autonomic University of Chihuahua, Chihuahua, México
- 4 Nursing Faculty, Autonomic University of San Luis Potosí, San Luis Potosí, México
- 5 Nursing Faculty, Autonomic University of San Luis Potosí, San Luis Potosí, México
Abstract
Objective: To determine the acceptability of self-taken vaginal to detect HPV DNA in women living in marginalized areas as an alternative to increase the coverage of health services. Methods: A cross-sectional study from March 2009 to April 2011 in 20 municipalities with the highest marginalization in the Huasteca Region of the State of San Luis Potosi, México. We applied a non-probabilistic quota sampling, which was composed of 608 women aged 25 years and more. The re cruitment of women was performed through loudspeakers, leaflets and community meetings. A survey consisted of two sections: socio-demographic data and risk factors, which was validated by construct. We checked the reliability by Cronbach’s Alpha (0.90). Acceptability was determined by considering three indicators: perceived comfort, acceptability of the test and the reasons of acceptability. Results: 41.4% of this woman had 31-40 years. 70.5% were married. 35.3% finished high school and 6.7% had not education experience. 67.4% began their sexual life at 18 years or younger. 85.5% preferred self-collection and 14.5% Pap. These results show a clear acceptability of self-making on the other screening method. Regarding the reason for the preference is that 99.4% of women prefer self-take because they feel more comfortable compared to 0.6% who prefer the Papanicolaou. On the perception of comfort 91% mentioned feel very comfortable with self-making compared with 9% of Pap. There was a statisti cally signifi cant correlation between preference reasons that women have to choose the screening test and the perception of comfort ( X 2 p = 0.000). Conclusions: The self-taken vaginal HPV DNA detection is a well accepted method in women who live in marginalized areas; therefore, it is an alternative that can be considered in the uterine cancer detection testing program.
- Alterio, G., Mendoza, I., Mendoza, R., Peraza, E., Pérez, H. and Sánchez, A. (2007) Cytological findings and pathology risk factors for preinvasive and invasive cervical cancer. Area of influence of urban ambulatory type II. Revista Public Health and Nutrition, 8, 1-29. http://www.respyn.uanl.mx/index.html
- López, A. and Lizano, M. (2006) Cervical cancer and human papilloma virus that does not end the story. Journal of the National Cancer Institute Mexico, 1, 31-55.
- Castellano, M.R. (2003) Cervical cancer and HPV. Detection options. Revista de la Facultad de Medicina, 46, 63-65.
- Ferlay, J., Bray, F., Pisani, P. and Parkin, D.M. (2000) GLOBOCAN: Cáncer, incidence, mortality and prevalence worldwide. Versión 1.0. IARC Cancer Base No. 5. Lyon: IARC. http://onlinelibrary.wiley.com/doi/10.1002/ijc.25516/full
- Government of México (2007) National Institute of Statistics, Geography and Informatics. Morbidity and mortality statistics by state. INEGI, Mexico DF.
- Lewis, M.J. (2004) Situational analysis of cervical cancer in Latin America and the Caribbean. Pan American Health Organization/World Health Organization (OPS/ OMS), 1-33.
- Lazcano-Ponce, E.C., Castro, R., Allen, B., Nájera-Aguilar, P., Alonso-de-Ruiz, P. and Hernández-ávila, M. (1999) Barriers to early detection of cervical uterine cancer in Mexico. Journal of Women’s Health, 8, 399-408. http://dx.doi.org/10.1089/jwh.1999.8.399
- Cox, J.T., Lorincz, A.T., Schiffman, M.H., Sherman, M.E., Cullen, A. and Kurman, R.J. (1995) Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. American Journal of Obstetrics & Gynecology, 172, 946-954. http://dx.doi.org/10.1016/0002-9378(95)90026-8
- Snijders, P. (2011) Milestones in a decision process. HPV Today Newsletter of Human Papillomavirus. Holland Special Edition. www.hpvtoday.com
- Gok, M., van Kemenade, F.J., Heideman, D.A., Berkhor, J., Rozendaal, L., Spruyt, J.W., et al. (2010) HPV testing on self-collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: Cohort study. BMJ, 340, c1040. http://dx.doi.org/10.1136/bmj.c1040
- Sanner, K., Wilkstrom, I., Strand, A., Lindell, M. and Wilander, E. (2009) Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. British Journal of Cancer, 101, 871-874. http://dx.doi.org/10.1038/sj.bjc.6605194